We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
Oxford spinout developing novel therapeutics based on deep expertise in immune cell regulation.
MoA Technology, borne out of Oxford University research, launches to confront the global herbicide resistance crisis with £6.3m Series A funding round.
Oxford Brain Diagnostics sets out with the goal of improving the treatment of Alzheimer’s by enabling early and accurate detection
The Oxford University spinout company launches to look inside the brain for novel markers of disease.
The visual data exploration company charges up for next stage of its evolution.
Osage University Partners and Oxford University Innovation sign MoU on investment into Oxford University spinouts.
Blue Water Vaccines, developing universal flu vaccine, completes $7m financing following successful preclinical study
Vaccine based on pioneering mathematical models, research from University of Oxford.
Virology spinout Theolytics emerges from stealth with £2.5m seed and Dr Ken Powell as chair.